BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9088889)

  • 1. Combined antibody screening for improved prediction of IDDM--modern strategies.
    Roll U; Ziegler AG
    Exp Clin Endocrinol Diabetes; 1997; 105(1):1-14. PubMed ID: 9088889
    [No Abstract]   [Full Text] [Related]  

  • 2. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
    Ongagna JC; Levy-Marchal C
    Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
    Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
    Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P
    Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS; Colman PG; Harrison LC
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
    Thivolet C
    Journ Annu Diabetol Hotel Dieu; 1992; ():165-71. PubMed ID: 1495236
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
    Bieg S; Seissler J; Scherbaum WA
    Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923
    [No Abstract]   [Full Text] [Related]  

  • 11. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
    Bonifacio E; Bingley PJ
    Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prediction of type I diabetes by antibody screening].
    Roll U; Ziegler AG
    Fortschr Med; 1995 Sep; 113(26):365-7. PubMed ID: 7498855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
    Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
    Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Islet cell antibodies].
    Hanafusa T
    Rinsho Byori; 1995 May; 43(5):460-2. PubMed ID: 7783363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies as predictors of type 1 diabetes.
    Wilkin TJ
    Compr Ther; 1991 Jul; 17(7):3-10. PubMed ID: 1742966
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
    Bingley PJ; Bonifacio E; Gale EA
    Lancet; 1994 Jul; 344(8917):266-7. PubMed ID: 7913179
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers.
    Bingley PJ; Bonifacio E; Williams AJ; Genovese S; Bottazzo GF; Gale EA
    Diabetes; 1997 Nov; 46(11):1701-10. PubMed ID: 9356015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.